AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control ...

New website lists only limited number of medications – and many of them cost less in generic form elsewhere ...

The approval paves way for the marketing of durvalumab solution for infusion 120mg/2.4ml and 500mg/10ml (Imfinzi) in India ...

Shares edged 1% higher in morning trading on Tuesday, with the stock having risen 28% in the past six months.

Drug regulator clears Durvalumab combo therapy for advanced or recurrent endometrial cancer, subject to statutory approvals ...

Pharmaceutical heavyweight AstraZeneca has recorded a 40% leap in annual profits and forecasted continued earnings growth ...

The FTSE 100-listed firm reported that sales and profit rose 8 and 11%, respectively, in line with its forecasts.

FDA grants Priority Review to DATROWAY (datopotamab deruxtecan-dlnk) in the U.S. for advanced triple negative breast cancer. EU CHMP issues a positive opinion for Imfinzi (durvalumab) plus ...

AstraZeneca Plc expects profit to grow further this year, boosted by sales of its cancer drugs as it works to offset a patent expiry of a blockbuster diabetes medicine.

In a new video, social media star Aishwarya Mohanraj has opened up about her weight loss journey with Mounjaro. Social media users are appreciating her for being honest.

After ending 2025 with a strong fourth quarter, AstraZeneca management has doubled down on its ambitious “$80 billion by 2030 ...